Key result
TEVAR with reentry closure achieves ~77% clinical success in chronic type B aortic dissection.
Why the study?
Does TEVAR with reentry closure improve clinical success and survival in patients with chronic type B aortic dissection?
Observational (n=13)
No
Does TEVAR with reentry closure improve clinical success and survival in patients with chronic type B aortic dissection?
Answers are grounded in this paper and cite their sources.
TEVAR with reentry closure for chronic type B aortic dissection achieved a 76.9% clinical success rate with complete false lumen thrombosis, suggesting it may prevent false lumen dilatation or rupture.
TEVAR with reentry closure suggests preventing FL dilatation or rupture in CTBAD, but the revision of our devices and further research with more patients and longer follow-up periods are required.
No takes yet. Share an insight, caveat, or question.
Chiba et al. (2022) conducted an observational in Chronic type B aortic dissection with aneurysmal dilatation (n=13). Thoracic endovascular aortic repair (TEVAR) with reentry closure was evaluated on Clinical success (complete false lumen thrombosis). In patients with chronic type B aortic dissection, TEVAR with reentry closure achieved a clinical success rate of 76.9% and a 5-year overall survival rate of 64.8%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: